Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

October 16, 2023 / 2023 Power 25 Health Care

2023 Power 25 Health Care: Jean-Michel Boers

Click here to go back to the 2023 Power 25 Health Care home page
More Information

Jean-Michel Boers has been working for pharmaceutical company Boehringer Ingelheim for more than 25 years, and he took over as president and CEO of its U.S. operations in 2020.

The company’s U.S. headquarters is based in Ridgefield.

Prior to his promotion, Boers served as president of Boehringer Ingelheim Pharmaceuticals, the company’s largest U.S. subsidiary, a role he took over in 2017.

Boers is responsible for the company’s U.S. commercial and medical operations, including development of its drug portfolio and preparing for future launches.

Boers originally joined Boehringer Ingelheim in 1998 in Belgium. During his career there, he has had multiple leadership roles, including in Germany and France.

Boers came to the United States in 2016 as senior vice president of the specialty care franchise, then rose to lead the U.S. human pharmaceutical business in January 2017. In that role, he steered growth and development of the company’s portfolio.

Boehringer Ingelheim makes medications for both humans and animals. The company, originally founded back in 1885, is an independent and family-owned business. The company has more than 53,000 employees worldwide, including over 13,000 in the Americas.

In 2022, Boehringer Ingelheim recorded net sales of 24.1 billion euros, or $25.4 billion. The company is known for drugs such as Jardiance, an anti-diabetic medication.

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF